100
Participants
Start Date
April 25, 2024
Primary Completion Date
October 1, 2024
Study Completion Date
December 1, 2024
VEXUS score
The VExUS score is obtained as follows: VEXUS 0: IVC \< 20mm; VEXUS 1: IVC ≥ 20mm with normal patterns or mild abnormalities; VEXUS 2: IVC ≥ 20mm with severe abnormality in at least one pattern and VEXUS 3: IVC ≥ 20mm and severe abnormalities in multiple patterns.
NGAL
Neutrophil gelatinase-associated lipocalin
Inonu University
OTHER